Geneva Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$82.8M Sell
637,735
-312,110
-33% -$38.2M 1.43% 18
2017
Q1
$118M Buy
949,845
+41,500
+5% +$4.97M 2.11% 8
2016
Q4
$105M Buy
908,345
+232,542
+34% +$25.9M 2.05% 8
2016
Q3
$70.6M Buy
675,803
+16,350
+2% +$1.77M 1.33% 20
2016
Q2
$65M Sell
659,453
-263,811
-29% -$27.3M 1.29% 22
2016
Q1
$92.4M Sell
923,264
-145,157
-14% -$14.9M 1.86% 9
2015
Q4
$128M Sell
1,068,421
-101,176
-9% -$11.7M 2.46% 5
2015
Q3
$127M Buy
1,169,597
+37,301
+3% +$4.63M 2.55% 2
2015
Q2
$131M Sell
1,132,296
-161,326
-12% -$18.4M 2.34% 2
2015
Q1
$149M Sell
1,293,622
-11,354
-0.9% -$1.36M 2.7% 1
2014
Q4
$146M Sell
1,304,976
-31,313
-2% -$3.3M 2.72% 1
2014
Q3
$127M Sell
1,336,289
-61,359
-4% -$5.54M 2.39% 2
2014
Q2
$120M Sell
1,397,648
-103,734
-7% -$7.89M 2.19% 2
2014
Q1
$105M Buy
1,501,382
+107,354
+8% +$8.5M 1.93% 5
2013
Q4
$118M Buy
1,394,028
+32,962
+2% +$2.61M 2.17% 5
2013
Q3
$105M Buy
1,361,066
+180,882
+15% +$12.7M 2.18% 3
2013
Q2
$69M Buy
+1,180,184
New +$71M 1.61% 18

Other funds holding CELG

Geneva Advisors's CELG Position: Q2 2017 in Review

Geneva Advisors reduced its Celgene Corp (CELG) stake by 33% in Q2 2017, selling an estimated $38.2M and leaving 637,735 shares worth $82.8M. The position accounts for 1.43% of the portfolio, ranked #18.

Geneva Advisors first reported a position in CELG in Q2 2013 and has held it in 17 quarters since. The position peaked at $149M in Q1 2015. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • Geneva Advisors held 637,735 shares of Celgene Corp worth $82.8M as of Q2 2017.
  • Geneva Advisors sold 312,110 Celgene Corp shares in Q2 2017, an estimated $38.2M.
  • Celgene Corp made up 1.43% of Geneva Advisors's portfolio in Q2 2017, its #18 holding.
  • Geneva Advisors first reported a position in Celgene Corp in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Celgene Corp position peaked at $149M in Q1 2015.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.